PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $458,000 | +3423.1% | 141,208 | +3392.7% | 0.00% | – |
| Q1 2016 | $13,000 | -99.3% | 4,043 | -98.6% | 0.00% | -100.0% |
| Q1 2015 | $1,988,000 | -13.2% | 282,653 | -4.8% | 0.00% | -20.0% |
| Q4 2014 | $2,290,000 | -14.1% | 297,020 | -16.8% | 0.01% | -16.7% |
| Q3 2014 | $2,666,000 | -9.9% | 357,020 | +16.8% | 0.01% | 0.0% |
| Q2 2014 | $2,958,000 | -3.6% | 305,600 | -17.3% | 0.01% | -14.3% |
| Q1 2014 | $3,070,000 | +282.8% | 369,494 | +288.6% | 0.01% | +250.0% |
| Q4 2013 | $802,000 | +101.5% | 95,079 | +90.2% | 0.00% | +100.0% |
| Q3 2013 | $398,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |